KAZIA THERAPEUTICS LTDKZIAEarnings & Financial Report
Nasdaq
Kazia Therapeutics Ltd is a clinical-stage biotechnology company focused on developing targeted oncology therapies. Its lead pipeline candidates address rare pediatric brain cancers and other hard-to-treat solid tumor indications, with core business operations across Australia, the United States, and European markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 4.99% | 54.8K | ▼ -5.00pp | 2024-11-14 |
| s. | 3.96% | 1.6M | ▼ -6.03pp | 2024-08-12 |